Meetings with Karim Bardeesy reported by registered lobbyists. Lobbyists must report every oral, arranged meeting with an MP, minister or other designated public office holder.
← Karim BardeesyEvery reported meeting
Newest first, back to November 2021 if Karim Bardeesy held office then.
-
Reported by Melanie Woodin · In-house (organization)
- Karim Bardeesy · Parliamentary Secretary, Federal Economic Development Agency for Southern Ontario (FedDev)
Communications with various designated public office holders regarding jobs, creating skills development and work-integrated learning. Read more
Communications with various designated public office holders for increased funding to the Research Support Program of SSHRC, NSERC and CIHR.
Communications with various designated public office holders regarding investment in science and technology
-
Reported by Benjamin Bergen · In-house (organization)
- Karim Bardeesy · Member of Parliament
- Colin Deacon · Senator, Senate of Canada
The Council of Canadian Innovators (CCI) is engaging with government officials to discuss the alignment between CCI’s priorities and the federal government’s efforts to foster innovation in Canada. These discussions focus on ensuring that government programs and policies effectively support high-growth Canadian technology firms and strengthen the country’s innovation ecosystem. Read more
-
Reported by Dave Jamieson · In-house (corporation)
- Karim Bardeesy · Member of Parliament
- Yasmin Atassi · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
NATIONAL ZERO-EMISSIONS VEHICLE STRATEGY: Communicating with government officials about the National Zero-Emissions Vehicle Strategy, more specifically (i) providing expert industry input on the strategy, (ii) participating in various advisory groups and (iii) participating in the government review. These communications will involve discussions about design, infrastructure, incentives, supply, and public awareness. Read more
STRATEGIC RESPONSE FUND (SRF) AND STRATEGIC INNOVATION FUND ("SIF"): Communicating with government officials about funding under the Strategic Innovation Fund and the newly created Strategic Response Fund, to ensure and maintain the competitiveness of automobile manufacturing in Canada.
INTERNATIONAL TRADE: Communicating with government officials about international trade, more specifically trade issues and support measures related to the automotive industry and automotive manufacturing, including potential tariffs on automobiles, automotive parts and batteries.
-
Reported by Timothy Ross · In-house (organization)
- Karim Bardeesy · Member of Parliament
Lobbying to ensure that low-income households can continue to live affordably in federally-administered housing co-operatives after their operating agreements end with Canada Mortgage and Housing Corporation (CMHC). Read more
Lobbying for the development of new affordable housing, including co-operative housing.
-
Reported by Brian Kingston · In-house (organization)
- Karim Bardeesy · Member of Parliament
Ensure that federal ZEV policies support consumer uptake and demand, and comprehend the integrated nature of the auto industry and the need for alignment with U.S. federal ZEV policies and programs. Read more
Competitive industrial policies and supports such as the Strategic Innovation Fund.
-
Reported by Glenda Crisp · In-house (organization)
- Karim Bardeesy · Member of Parliament
- Paul Moen · Chief of Staff to the Minister, Innovation, Science and Economic Development Canada (ISED)
Pan-Canadian AI Compute Environment (PAICE) program progress and AI compute
-
Reported by Robert Annan · In-house (organization)
- Karim Bardeesy · Member of Parliament
Seeking funding support for genomics and related sciences research in Canada through the financing of Genome Canada's activities.
-
Reported by Tabatha Bull · In-house (organization)
- Karim Bardeesy · Parliamentary Secretary, Innovation, Science and Economic Development Canada (ISED)
- Ian Ketcheson · VP Indigenous Affairs, Impact Assessment Agency of Canada (IAAC)
- Peter Hammerschmidt · Assistant Deputy Minister, National Defence (DND)
Development and implementation of a Federal Indigenous Entrepreneurship Strategy; Read more
Increasing Federal procurement from Indigenous businesses.
-
Reported by James Brodie · In-house (corporation)
- Karim Bardeesy · Parliamentary Secretary to the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Discuss Canada’s talent attraction strategy as part of the expansion of the nation’s industrial and research capacity. Read more
Canada’s engagement in international trade agreements in particular Comprehensive and Economic Trade Agreement (CETA) and North American Free Trade Canada-United States-Mexico Agreement (NAFTACUSMA) and any other agreements as it relates to intellectual property considerations and other aspects which affect the local business environment for J&J companies.
-
Reported by Candace Laing · In-house (organization)
- Karim Bardeesy · Member of Parliament
- Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Chase Knight · Parliamentary Secretary Assistant and Parliamentary Affairs Advisor, Innovation, Science and Economic Development Canada (ISED)
HEALTH – Ensuring we improve access to necessary medicines by building on rather than displacing the important role of private insurers and respecting provincial and territorial jurisdiction. Read more
INDUSTRY - Encouraging the government to invest in cybersecurity research & development (R&D) and innovation; expanding and diversifying the cyber workforce and talent pipeline; supporting the secure digitalization of small-and-medium-sized enterprises (SMEs); and improving the global competitiveness of Canada’s cybersecurity industry.
-
Reported by David D. Jones · In-house (corporation)
- Karim Bardeesy · Member of Parliament
- Chase Knight · Parliamentary Secretary Assistant and Parliamentary Affairs Advisor, Innovation, Science and Economic Development Canada (ISED)
- Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Victoria Morton · Senior Communications Advisor, House of Commons
The government's Science and Technology strategy as it relates to the biopharmaceutical industry. Read more
Canada's Access to Medicines Regime with respect to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a business climate in Canada that continues to encourage research into further treatment and prevention of disease.
-
Reported by Bettina Hamelin · In-house (organization)
- Karim Bardeesy · Member of Parliament, and Parliamentary Secretary to the Minister of Industry
Free trade agreements as they relate to the biopharmaceutical industry Read more
Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations
-
Reported by Ugur Gunaydin · In-house (corporation)
- Karim Bardeesy · Parliamentary Secretary to the Minister of Industry
- Chase Knight · Parliamentary Secretary Assistant and Parliamentary Affairs Advisor, Innovation, Science and Economic Development Canada (ISED)
- Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Communicating, in general, with government officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy. Read more
-
Reported by Brigitte Nolet · In-house (corporation)
- Karim Bardeesy · Parliamentary Secretary Assistant, Innovation, Science and Economic Development Canada (ISED)
- Annahat Kochhar · Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
- Hosai Zurmati Halim · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
- Elizabeth Wong · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
and 5 moreShow fewer
- Chase Knight · Parliamentary Secretary Assistant and Parliamentary Affairs Advisor, Innovation, Science and Economic Development Canada (ISED)
- Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Victoria Morton · Senior Communications Advisor, House of Commons
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
Economic Growth Initiatives as it relates to pharmaceutical, clinical trials investment, life sciences industry
-
Reported by Paul Petrelli · In-house (corporation)
- Karim Bardeesy · Parliamentary Secretary, Innovation, Science and Economic Development Canada (ISED)
- Chase Knight · Parliamentary Secretary Assistant, Innovation, Science and Economic Development Canada (ISED)
- Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Victoria Morton · Senior Communications Advisor, House of Commons
Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector Read more
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.
Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.
-
Reported by Vince Lamanna · In-house (organization)
- Karim Bardeesy · Parliamentary Secretary to the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes. Read more
Free trade agreements as they relate to the biopharmaceutical industry.
Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry.
-
Reported by Rami Fayed · In-house (corporation)
- Karim Bardeesy · Parliamentary Secretary, Innovation, Science and Economic Development Canada (ISED)
- Chase Knight · Parliamentary Secretary Assistant and Parliamentary Affairs Advisor, Innovation, Science and Economic Development Canada (ISED)
Communication regarding free trade agreements as they relate to the biopharmaceutical industry. Read more
Communications regarding opportunities to speed patient access to live-saving medicines on publicly-funded drug formularies in Canada by reducing red tape.
Innovation, Science and Economic Development (ISED)'s Health Emergency Readiness program, insofar as it pertains to growth and development of the life sciences industry in Canada.
Communications regarding intellectual property protection of prescription drugs, including the Patent Act, the Patented Medicines Regulations, the Patented Medicine Notice of Compliance (PMNOC) Regulations, the Patent Term Adjustment regime and Health Canada’s Data Protection regime.
-
Reported by Sylvia Durgerian · In-house (corporation)
- Karim Bardeesy · Parliamentary Secretary, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · Interim Head, Health Emergency Readiness Canada, Innovation, Science and Economic Development Canada, Innovation, Science and Economic Development Canada (ISED)
- Annahat Kochhar · Policy Advisor, President’s Office, Treasury Board Of Canada Secretariat (TBS)
- Hosai Zurmati Halim · Senior Policy Advisor, President’s Office, Treasury Board Of Canada Secretariat (TBS)
and 9 moreShow fewer
- Elizabeth Wong · Senior Policy Advisor, President’s Office, Treasury Board Of Canada Secretariat (TBS)
- Chase Knight · Parliamentary Secretary Assistant and Parliamentary Affairs Advisor, Innovation, Science and Economic Development Canada (ISED)
- Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Victoria Morton · Senior Communications Advisor, Innovation, Science and Economic Development Canada (ISED)
- Greg Orencsak · Deputy Minister, Health Canada (HC)
- Sarah Lawley · Assistant Deputy Minister, Health Policy Branch, Health Canada (HC)
- Pamela Aung-Thin · Assistant Deputy Minister, Health Products and Food Branch, Health Canada (HC)
- Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
Related to the life sciences, research and the digital ecosystems, we need to make sure that Canada creates an environment that is globally competitive
-
Reported by Mark Lewis · In-house (corporation)
- Karim Bardeesy · MP
- Miro Froehlich · Director of Policy, Privy Council Office (PCO)
- Nasser Haidar · Senior Policy Advisor, Privy Council Office (PCO)
- Galen Richardson · Senior Advisor, Stakeholder Relations, Privy Council Office (PCO)
and 14 moreShow fewer
- Peter M. Boehm · Senator, Senate of Canada
- Martin Moen · Associate Assistant Deputy, Global Affairs Canada (GAC)
- Ritu Banerjee · ADM, Innovation, Science and Economic Development Canada (ISED)
- Annahat Kochhar · Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
- Hosai Zurmati Halim · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
- Elizabeth Wong · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
- Chase Knight · Parliamentary Secretary, Innovation, Science and Economic Development Canada (ISED)
- Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- victoria morton · Senior Communications Advisor,, House of Commons
- Greg Orencsak · Deputy Minister, Health Canada (HC)
- sarah Lawley · Assistant Deputy Minister, Health Canada (HC)
- Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
- Justine Frame · Special Assistant, Policy,, Health Canada (HC)
Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).
-
Reported by Daniel Moulton · Consultant
- Karim Bardeesy · Parliamentary Secretary, Innovation, Science and Economic Development Canada (ISED)
Build awareness of Live Nation’s role in the Canadian live event marketplace and discuss opportunities to grow arts and cultural experiences as Canada faces the impacts of the global pandemic. Read more
-
Reported by Terry Creighton · Consultant
- Karim Bardeesy · MP
- Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · ADM, Innovation, Science and Economic Development Canada (ISED)
- Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Advocate for supportive economic and tax policy for Canada's pharmaceutical manufacturing sector. Read more
Advocate for regulatory policy to support review of generic drug submissions from Canadian drug producers
Raise awareness of role of Canadian drug producers in exports to the U.S. and other parts of the world. Advocate for including Canada's drug exports as part of CUSMA negotiations
Work with government to promote and support Canada’s pharmaceutical manufacturing sector and advocating for supportive public policy
-
Reported by David Goodman · In-house (corporation)
- Karim Bardeesy · Député
- Paul Moen · Chef de cabinet, Innovation, Science and Economic Development Canada (ISED)
- Manuela Tomic · Conseillère principale en politiques, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.
-
Reported by Daniel Moulton · Consultant
- Karim Bardeesy · Parliamentary Secretary, Innovation, Science and Economic Development Canada (ISED)
To create an awareness of Ticketmaster’s role in the Canadian live event marketplace and discuss the government’s ongoing consideration of measures to protect consumers in live event ticketing. Read more
-
Reported by Beatrice Bruske · In-house (organization)
- Karim Bardeesy · Member of Parliament
Addressing the high cost of living and investing in affordable housing
-
Reported by Jeffrey Maddox · In-house (corporation)
- Evan Solomon · Minister of Artificial Intelligence and Digital Innovation, Innovation, Science and Economic Development Canada (ISED)
- Karim Bardeesy · Parlimentary Secretary, Innovation, Science and Economic Development Canada (ISED)
- Maninder Sidhu · Minister of International Trade, Global Affairs Canada (GAC)
- Jenna Sudds · Parlimentary Secretary, Public Services and Procurement Canada (PSPC)
Nokia Canada Inc. is exploring funding opportunities to expand its R&D footprint and talent pool in Canada. Additionally NOKIA is seeking oppportunities to earn opportunities to deploy our technology within these networks . Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.